Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» eye disease
eye disease
AbbVie and Capsida Biotherapeutics partner on eye disease focused gene therapies
AbbVie and Capsida Biotherapeutics partner on eye disease focused gene therapies
Biopharma Reporter
AbbVie
Capsida Biotherapeutics
eye disease
drug development
Flag link:
AbbVie, Capsida Set Sights on Gene Therapies for Eye Diseases
AbbVie, Capsida Set Sights on Gene Therapies for Eye Diseases
BioSpace
AbbVie
Capsida Biotherapeutics
gene therapy
eye disease
Flag link:
Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail
Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail
Fierce Biotech
Merck
NGM Biopharmaceuticals
clinical trials
eye disease
NGM621
geographic atrophy
Flag link:
Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment
Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment
Investors Business Daily
Apellis Pharmaceuticals
pegcetacoplan
eye disease
geographic atrophy
Flag link:
Hovione's drug delivery tech lands eye disease licensing deal
Hovione's drug delivery tech lands eye disease licensing deal
Fierce Pharma
Hovione
drug delivery
Ji Xing Pharmaceuticals
JX08
eye disease
Flag link:
Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect
Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect
Fierce Biotech
Oxurion
THR-687
eye disease
Flag link:
Intellia looks to eye diseases in latest deal
Intellia looks to eye diseases in latest deal
BioPharma Dive
Intellia Therapeutics
gene editing
eye disease
Flag link:
Can a topical treatment beat blockbuster eye injectables? A Swiss biotech has the cash now to find out
Can a topical treatment beat blockbuster eye injectables? A Swiss biotech has the cash now to find out
Endpoints
Oculis
eye disease
OCS-201
OCS-202
Flag link:
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug
Xconomy
Unity Biotechnology
restructuring
UBX1325
eye health
eye disease
Flag link:
Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease
Biogen boosts gene therapy strategy with Harvard pact focused on inherited eye disease
Fierce Biotech
Biogen
gene therapy
eye disease
Harvard
Flag link:
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis
AsclepiX Emerges With $35M and an Eye Drug Challenger to Eylea, Lucentis
Xconomy
AsclepiX Therapeutics
eye disease
Eylea
Lucentis
macular edema
wet age-related macular degeneration
retinal occulsion
AXT107
Flag link:
Novartis Considers Offer for Takeda Eye-Disease Assets
Novartis Considers Offer for Takeda Eye-Disease Assets
Bloomberg
Novartis
Takeda
Shire
eye disease
M&A
Flag link:
How this biotech plans to go up against big pharma with its eye disease products
How this biotech plans to go up against big pharma with its eye disease products
Drug Delivery Business News
biotech
Ocugen
eye disease
Flag link:
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Yahoo
Bayer
Regeneron
eye disease
nesvacumab
Aflibercept
Flag link:
Biogen enters eye-treatment arena with AGTC deal
Biogen enters eye-treatment arena with AGTC deal
Yahoo/Reuters
Biogen
M&A
AGTC
opthalmology
gene therapy
eye disease
Flag link:
Bayer bets on Johns Hopkins for eye disease R&D
Bayer bets on Johns Hopkins for eye disease R&D
Fierce Biotech
Bayer
eye disease
R&D
Johns Hopkins
Flag link:
Two Promising Gene Therapy Stocks Tackling Eye Disease
Two Promising Gene Therapy Stocks Tackling Eye Disease
TheStreet.com
Applied Genetic Technologies
Avalanche Biotechnologies
eye disease
Flag link:
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
Iridex
eye disease
Flag link:
Otsuka Pharma extends research collaboration with MethylGene
Otsuka Pharma extends research collaboration with MethylGene
Pharmabiz
Otsuka
MethylGene
eye disease
Flag link:
Alcon Boosts Presence In Eye Disease Market
Alcon Boosts Presence In Eye Disease Market
Yahoo/Investors Business Daily
eye disease
Alcon
Flag link: